The messenger logo

The News in Brief

Tuesday, June 29
Prepared by the Messenger Staff

New Study: Pfizer and Modern Vaccines May Provide Long-Term Immunity

Pfizer / Biotech and Moderna vaccines may help the body develop long-term immunity against the coronavirus. According to Forbes, this is discussed in a new study published on June 28.

According to research, those who have been vaccinated with the mRNA vaccine may be exposed to the so-called Do not need a booster dose.

In a study published in the scientific journal Nature, the scientists found that these vaccines elicited a strong immune response, which could provide years of protection against Covid-19.

The study also reinforces a previous report published in May, which found that people who underwent COVID-19 infection and then injected with both doses of mRNA vaccine had the strongest immune response to the virus.

The study also showed that the vaccines produced high levels of neutralizing antibodies that are effective against three different variants of the coronavirus, including the ‘beta’ variant.

The scope of the study was limited to the two authorized vaccines produced by Moderna and Pfizer.

However, it does not provide much information about the ‘delta’ (Indian) variant of the coronavirus, which is the most contagious strain compared to others.

According to the results of this study, the majority of people who have been vaccinated with the mRNA vaccine are likely to be protected for a long time, however, the emergence of new, highly contagious strains may still weaken the efficacy of mRNA vaccines.

According to the Minister of Health Ekaterine Tikaradze, it will be possible to start a mass vaccination as one million doses of Sinopharm and Sinovac should be in Georgia by the end of the week.